Use of aerosolized colistin sodium in cystic fibrosis patients awaiting lung transplantation

Transplantation

Volumn 64, Issue 5, 1997, Pages 748-752

  Bauldoff, Gerene S ^a,b   Nunley, David R ^c   Manzetti, Jan D ^c   Dauber, James H ^c   Keenan, Robert J ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b 360 Victoria Building ^*  (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; CEPHALOSPORIN DERIVATIVE; COLISTIMETHATE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AEROSOL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CYSTIC FIBROSIS; EXPLANT; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; NEBULIZER; PRIORITY JOURNAL; PSEUDOMONAS; RECIPIENT; SPUTUM CULTURE;

AEROSOLS; COLISTIN; CYSTIC FIBROSIS; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS; SPUTUM;

EID: 0030961155     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199709150-00015     Document Type: Article

References (18)

1. Fick RB, Stillwell PC. Controversies in the management of pulmonary disease due to cystic fibrosis. Chest 1989; 95: 1319.
2. Cystic Fibrosis Foundation National Cystic Fibrosis Registry 1994 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation, 1995.
3. Hodson ME. Antibiotic treatment: aerosol therapy. Chest 1988; 94(2): 1565.
4. Ramsey BW, Dorkin HL, Eisenberg JD, et al. Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med 1993; 328: 1740.
5. Saint Louis International Transplant Registry Data. St. Louis, MO, September 1995.
6. Steinbach S, Sun L, Ru-Zhang J, et al. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med 1994; 331: 981.
7. Griffith BP, Hardesty RL, Armitage JM, et al. A decade of transplantation. Ann Surg 1993; 218(3): 310.
8. Consensus Conference: Concepts in care, Vol. 5, Sec. 1. Cystic Fibrosis Foundation, May 1994.
9. Nunley DR, Williams PA, Bauldoff GS, et al. Pseudomonas colonization and infection in cystic fibrosis lung transplant recipients (abstract). Pediatr Pulmonol 1995; 12(suppl): 278.
10. Nunley DR, Manzetti JD, Bauldoff GS, et al. Predictors of survival in cystic fibrosis pre and post transplant: the Pittsburgh experience [Abstract]. Pediatr Pulmonol 1994; 10(suppl): 333.
11. Stead RJ, Hodson ME, Batten JC. Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa. Br J Dis Chest 1987; 81: 272.
12. Rouby JJ, Poete P, Martin de Lassale E, et al. Prevention of gram negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients: histologic and bacteriologic study. Int Care Med 1994; 20(3): 187.
13. Valerius NH, Koch C, Hoiby N. Prevention of chronic Pseudomonos aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991; 338: 725.
14. Stratton CW, Tansk F. Intrinsic resistance of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1989; 33: 526.
15. Hancock REW, Woodruff WA. Roles of porin and β-lactamase in β-lactam resistance. Rev Infect Dis 1989; 10: 770.
16. Poole K, Heinrichs DE, Neshat S. Cloning and sequence analysis of an EnvCD homologue in Pseudomonas aeruginosa. Mol Microbiol 1993; 10: 529.
17. Poole K, Krebes K, McNally C, Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 1993; 175: 7363.
18. Thomassen MJ, Klinger JD, Badger SJ, et al. Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis. J Pediatr 1984; 104: 352.